Showing results (161-170 of 203) with videos related to
Sort By:
Pageof 21
European Journal of Medicinal Chemistry|May 28, 2003
Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analoguesSunkyung Lee, Kyu Yang Yi, Soo-Kyung Kim, et al.Diabetes & Metabolism Journal|March 17, 2022
Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled StudyHae Jin Kim, In Kyung Jeong, Kyu Yeon Hur, et al.Plos One|February 25, 2021
Hedgehog proteins create a dynamic cholesterol interfaceAmirhossein Mafi, Rahul Purohit, Erika Vielmas, et al.Diabetes/Metabolism Research and Reviews|June 1, 2007
The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF ratsSung Hee Choi, Zheng Shan Zhao, Yong Jik Lee, et al.Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress-induced cytotoxicityXuyu Yang, Joo-Youn Lee, Farbod Moghadam, et al.Diabetes/Metabolism Research and Reviews|December 4, 2003
Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal modelSoo Kyung Kim, Zheng Shan Zhao, Yong Jik Lee, et al.Bioorganic & Medicinal Chemistry|May 15, 2004
Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-positionMichihiro Ohno, Zhan-Guo Gao, Philippe Van Rompaey, et al.Drug Development Research|July 8, 2022
Engineering of A3 Adenosine and P2Y Nucleotide Receptors and Their LigandsKenneth A Jacobson, Hak Sung Kim, Gnana Ravi, et al.Cell Reports. Physical Science|March 10, 2022
Complete inhibition of a polyol nucleation by a micromolar biopolymer additiveXin Wen, Sen Wang, Robert Ramji, et al.Diabetes Research and Clinical Practice|December 29, 2004
Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitusYoo Mee Kim, Bong Soo Cha, Dae Jung Kim, et al.Pageof 21